• 제목/요약/키워드: eudragit

검색결과 77건 처리시간 0.026초

유드라짓 및 폴리에틸렌글리콜 고체 매트릭스로 제조한 히드로코르티손 좌제의 서방성 평가 (Evaluation of Hydrocortisone Sustained-Release Suppositories Prepared with Eudragit-Polyethylene Glycol Solid Matrix)

  • 한건;김학형
    • Journal of Pharmaceutical Investigation
    • /
    • 제20권1호
    • /
    • pp.13-18
    • /
    • 1990
  • Hydrocortisone (HC) sustained-release suppositories were prepared by using a solid matrix of methacrylic acid-methacrylic acid methyl ester copolymer $(Eudragit\;L_{100}^{R}:\;EL)$ as a poorly water soluble carrier and polyethylene glycole 1540 (PEG) as an water soluble carrier. HC release rate was controlled by complexation with ${\beta}-cyclodextrin$ $({\beta}-CyD)$ which was confirmed by X-ray diffractometry, IR-spectroscopy and differential scanning calorimetry. Release rate of HC from the EL-PEG matrix suppositories decreased with increase of EL contents. The release rale from $HC-{\beta}-CyD$ complex decreased in the following order: $HC-{\beta}-CyD/PEG$ > HC/PEG > $HC-{\beta}-CyD/EL_{10%}-PEG$ > $HC/EL_{10%}-PEG$ > $HC-{\beta}-CyD/EL_{15%}-PEG$ > $HC/EL_{15%}-PEG$ > $HC-{\beta}-CyD/EL_{20%}-PEG$ > $HC/EL_{20%}-PEG$. The crystallinity of HC in polymer matrix was identified using X-ray diffractometer and the surface of matrix suppositories after release test was examined by scanning electron microscopy. The sustained release of HC from these matrix suppositories was attributed to the network structure of EL.

  • PDF

케토프로펜-${\beta}$-시클로덱스트린 고체분산체의 마이크로캅셀화 및 제어 방출 (Preparation and Controlled Release of Microcapsules Containing $Ketoprofen-{\beta}-Cyclodextrin$ Solid Dispersion)

  • 전인구;박정화
    • Journal of Pharmaceutical Investigation
    • /
    • 제22권1호
    • /
    • pp.33-40
    • /
    • 1992
  • This study was aimed to control the release characteristics of ketoprofen by microencapsulating $ketoprofen-{\beta}-cyclodextrin\;(KF-{\beta}-CyD)$ solid dispersion with Eudragit RS by the phase separation method using a nonaqueous vehicle. KF alone was also microencapsulated with Eudragit RS by the evaporation process in water phase. The results obtained showed that it was not possible to microencapsulate KF alone by phase separation in a chloroform-cyclohexane system while it was easy to microencapsulate $(KF-{\beta}-CyD)$ solid dispersion system. For the microcapsules, the release test was performed in the first fluid (pH 1.2) and the second fluid (pH 6.8) of K.P.V disintegration medium at $37^{\circ}C$. The release of KF from $(KF-{\beta}-CyD)$ solid dispersion microcapsules (1:1 core wall ratio) was more sustained than that from KF microcapsules, and followed zero-order kinetics. Especially, solid dispersion microcapsules showed pH-independent release patterns with higher wall to core ratio (1:1 w/w).

  • PDF

나프록센 함유 방출제어형 패취의 제제설계 및 평가 (Formulation and Evaluation of Controlled Release Patch Containing Naproxen)

  • 이계주;홍석천;황성주
    • Journal of Pharmaceutical Investigation
    • /
    • 제29권4호
    • /
    • pp.343-348
    • /
    • 1999
  • The purpose of this study is to prepare the controlled release adhesive patch containing naproxen. Pressuresensitive adhesive (PSA)-type patch was fabricated by casting of polyisobutylene (PIE.) and mineral oil in toluene. Membrane-controlled release (MCR)-type patch was prepared by the attachment of the controlled release membrane on the PSAtype patch. The membrane was mainly composed of Eudragit, polyethylene glycol(PEG) and glycerin. The drug release profile and skin permeation test with various patches were evaluated in vitro. The release of naproxen from PIE-based PSAtype patch with various loading doses fitted Higuchi's diffusion equation. However, the permeation of naproxen through hairless mouse skin from PSA-type patch followed zero-order kinetics. In MCR-type patch, thickness of controlled release membrane affected on the drug release rate highly. In the composition of membrane, the release rate was decreased as the ratio of Eudragit increased. The drug release from the MCR-type patch followed zero order kinetics. The permeation of naproxen through hairless mouse skin from MCR-type patch showed lag time for the intial release period and didn't fit the zero-order kinetics

  • PDF

이온교환수지 - 브롬화수소산덱스트로메토르판 복합체의 서방성 마이크로캅셀 개발에 관한 연구 (Development of Sustained Release Microcapsules Containing Ion Exchange Resin-Dextromethorphan Hydrobromide Complex)

  • 김종국;황수원;황성주;나운용
    • Journal of Pharmaceutical Investigation
    • /
    • 제19권2호
    • /
    • pp.99-107
    • /
    • 1989
  • In order to develop a pediatric liquid preparation with sustained release properties, dextromethorphan hydrobromide (DEXT) was complexed with strong cation exchange resin (CG 120) and the-complex was coated with Eudragit RS using a phase separation method by non-solvent addition. The effect of pH, ionic strength of the release medium and drug/resin ratio on the release rate of DEXT was studied. The release rate of free drug from the uncoated complex, and coated complexes with 9.5 and 18.5% Eudragit RS in artificial gastric juice were measured. The release rate from the uncoated complex was faster with higher pH, higher ionic strength of the release medium and higher drug/resin ratio. The release rate from the coated complex could be controlled by the amount of coating material, and the surface after release did not rupture into.

  • PDF

제어 방출협 캅토프릴 마이크로캅셀의 제조 및 용출 특성 (The Preparation of Controlled-Release Microcapsules for Captopril and Their Dissolution Characteristics)

  • 최현순;장혁;이계원;지웅길
    • Journal of Pharmaceutical Investigation
    • /
    • 제28권1호
    • /
    • pp.7-13
    • /
    • 1998
  • The captopril microcapsules were prepared and were investigated by measuring their size distribution using Scanning Electron Microscopy(SEM) and dissolution of captopril. Cetyl alcohol microcapsules prepared by emulsion melted-cooled method with various ratios of drug to cetyl alcohol were spherical and uniform. The release rate of cetyl alcohol microcapsules was decreased proportionally as the content of cetyl alcohol increased but, the particle size of microcapsules was increased. The surface of cetyl alcohol microcapsules was comparatively rough as drug content increased. Pellet type microcapsules were prepared using fluidized-bed coating system by spraying captopril solution on nonpareil-seeds followed by applying $Eudragit^{\circledR}$ RS solution containing propylene glycol as a plasticizer. The release rate of drug from pellet type microcapsules decreased as the content of $Eudragit^{\circledR}$ RS increased.

  • PDF

Evaluation of pH-sensitive Eudragit E100 Microcapsules Containing Nisin for Controlling the Ripening of Kimchi

  • Ko, Sung-Ho;Kim, Han-Soo;Jo, Seong-Chun;Cho, Sung-Hwan;Park, Wan-Soo;Lee, Seung-Cheol
    • Food Science and Biotechnology
    • /
    • 제14권3호
    • /
    • pp.358-362
    • /
    • 2005
  • Eudragit E100 microcapsules containing nisin were prepared and employed to control the ripening of kimchi. The recovery yields of microcapsules without/with nisin ranged from 93.53 to 94.61 % and 92.85 to 94.09 %, respectively. The particle size of microcapsules decreased (>200 to $100\;{\mu}m$) as the amount of aluminium tristearate increased from 6.0 to 15 %. The microcapsules were morphologically spherical and possessed rough surface. Nisin was completely released from the microcapsules within a day at pH 3.0 and within two days at pH 4.0, 5.0, and 6.0, respectively, whereas half the amount of nisin was released at pH 7.0 within two days. During fermentation of kimchi with microcapsules containing nisin, the pH decrease was retarded which resulted in a constant pH of approximately 4.2. The pH of 4.2 was optimal for ripening of kimchi for a longer period of time when compared with samples without nisin.

알긴산 나트륨의 코팅이 삼투정 펠렛의 약물방출에 미치는 영향 (The Effect of Sodium Alginate of Osmotic Pellet on Drug Release)

  • 윤주용;구정;이수영;김문석;이봉;강길선;이해방
    • 폴리머
    • /
    • 제32권2호
    • /
    • pp.103-108
    • /
    • 2008
  • 삼투정 펠렛은 경구를 통한 약물전달 시스템에 폭넓게 사용되고 있으며, 이러한 삼투정 펠렛은 수팽윤성 시드층과 모델약물인 니페디핀을 포함하는 약물층 그리고 약물의 방출을 조절하는 반투막 층으로 구성되어 있다. 이번 연구에서는 모델약물인 니페디핀을 포함한 삼투정 펠렛을 제조하고, 반투막층으로 사용되는 초산셀룰로오스(CA)와 Eudragit RS의 코팅두께에 따른 약물방출 거동과 알긴산 나트륨과 알긴산 나트륨의 가교가 삼투정 펠렛의 약물방출에 미치는 영향에 대하여 확인하고자 하였다. 모델약물인 니페디핀을 포함한 삼투정 펠렛의 제조는 유동층코팅기를 이용하여 제조하였으며, 비교적 높은 코팅 수율로 $1500{\sim}1700{\mu}m$ 내외의 펠렛이 제조됨을 SEM을 통하여 확인하였다. 이렇게 얻어진 펠렛의 반투막 층의 코팅두께에 따른 약물방출 거동을 보면 반투막의 코팅 두께가 증가할수록 약물의 방출이 지연됨을 확인하였다. 알긴산 나트륨을 반투막층 위에 코팅하였을 경우 인공위액(pH 1.2)에서는 약물방출이 거의 일어나지 않았으며, 인공장액(pH 6.8)으로 교체한 후 약물방출이 서서히 증가함을 알 수 있었다. 또한 알긴산 나트륨을 염화칼슘을 이용하여 가교시켰을 경우 약물의 방출이 급격히 감소함을 알 수 있었다. 이번 실험을 통하여 삼투정 펠렛의 약물방출은 반투막충의 코팅두께에 영향을 받으며, 알긴산 나트륨이 삼투정 펠렛의 약물방출에 영향을 끼침을 확인하였다.

수용성 염산슈도에페드린과 난용성 테르페나딘의 구형정석조립법과 액중미립구법을 이용한 서방성펠렛 복합제제의 개발 (Development of Multiparticulate-system Composed of Sustained Release-microspheres of Pseudoephedrin${\cdot}$HCI and Immediate Release-pellets of Terfenadine Using Solvent Evaporation Method and Spherically Agglomerated Crystallization Process)

  • 이계주;도기찬;김은희;박종범;황성주
    • 약학회지
    • /
    • 제41권3호
    • /
    • pp.305-311
    • /
    • 1997
  • Sustained release-microspheres and immediate release-pellets were prepared to develop a controlled release multiparticulate system containing both water soluble and insoluble dr ug. Pseudoephedrin.HCl (EPD) and terfenadine (TRF) were used as model drugs, respectively. Sustained release-EPD microspheres were prepared by solvent evaporation method using Eudragit RL or RS as a matrix combined with pH-insensitive film coating. Smaller EPD microspheres were obtained when smaller amount of Eudragit as a matrix material or larger amount of magnesium stearate as a dispersing agent was used. However the obtained microspheres did not show syfficient sustained release characteristics. About 97% of EPD was released after 1 hr irrespective of matrix material used. Subsequent coating of the microspheres with pH-insensitive polymer such as Eudragit RS or ethylcelulose (EC) resulted good sustained in 37.5, 73.3 and 92.0% release of encapsulated EPD in distilled water after 1, 3 abd 7 hr, respectively. It corresponds to mean dissolution time (MDT) of 2.3 hr, which is much larger than that of un-coated EPD microspheres (0.0048 hr). Immediate release TRF pellets were prepared by spherically agglomerated crystallization using Eudragit E as an inert matrix and methylene chloride as a liquid binder. Using Eudragit E alone as a matrix resulted in satisfactory physical properties of the pellets such as sphericity, surface texture and flowability, but led to slower release of TRF from pellets than un-modified TRF powder (MDT of 1.70 vs 1.43 hr in pH 1.2 dissolution medium). Introducing propylene glycol or sodium lauryl sulfate as an emulsifier brought about faster release of TRF from pellets (MDT of 1.14 and 0.95 hr, respectively). In conclusion, microencapsulation by solvent evaporation combined with film coating and spherically agglomerated crystallization were successfully utilized to prepare controlled release multiparticulate system composed of sustained release EPD-microspheres and immediate release TRF pellets.

  • PDF

PVP K30/Eudragit EPO에 의한 셀레콕시브 고체분산체의 용출률 향상 및 특성 (Characterization and Improvement of Dissolution Rate of Solid Dispersion of Celecoxib in PVP K30/Eudragit EPO)

  • 전대연;장지은;이정환;양재원;박상미;임동권;강길선
    • 폴리머
    • /
    • 제38권4호
    • /
    • pp.434-440
    • /
    • 2014
  • 셀레콕시브는 높은 결정성을 갖는 난용성 약물로서 이러한 난용성 약물의 용해도를 증진시키기 위해 고체분산법을 바탕으로 한 분무건조기를 이용하여 고체분산체를 제조하였다. PVP K30과 Eudragit EPO를 수용성 담체로 사용하였고 폴록사머 407은 계면활성제로 사용하였다. 제조된 셀레콕시브 고체분산체의 특성을 SEM, DSC, XRD 그리고 FTIR을 이용하여 확인하였다. SEM과 DSC 그리고 XRD를 통하여 셀레콕시브 고체분산체가 무정형임을 알 수 있었다. 제조된 고체분산체는 pH 1.2에서 용출을 실시하였으며 시판제인 Celebres$^{(R)}$ 용출률을 비교하였으며 분무건조를 통해 제조한 고체분산체가 Celebres$^{(R)}$보다 용출률이 크다는 것을 확인하였다.